Clik here to view.
Study Shows Positive Clinical and Potential Economic Outcomes with V.A.C....
SAN ANTONIO Acelity is pleased to announce the publication of a peer-reviewed study that suggests V.A.C. VeraFlo™ Therapy (NPWTi-d) may be more cost effective than standard V.A.C.® Therapy (NPWT)....
View ArticleClik here to view.
Takeda Announces Abstracts for ADCETRIS® (brentuximab vedotin) in Hodgkin...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that abstracts of interest from studies on VELCADE® (bortezomib), ADCETRIS® (brentuximab vedotin)...
View ArticleClik here to view.
pSivida Corp. Reports First Quarter FY 2015 Results
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced financial results for its...
View ArticleClik here to view.
R-Tech Ueno: Completion of a Phase I/II Clinical Study of Recombinant Human...
TOKYO R-Tech Ueno (JASDAQ:4573): This is to announce the completion of a Phase I/II clinical study of recombinant human serum albumin-containing ophthalmic solution (development code: RU-101) for...
View ArticleClik here to view.
武田宣布，ADCETRIS® (brentuximab...
马萨诸塞州坎布里奇和日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502)今天宣布，该公司关注的VELCADE® （硼替佐米）、ADCETRIS® (brentuximab vedotin)和研究中的口服蛋白酶体抑制剂ixazomib...
View ArticleClik here to view.
GE Healthcare and Takeda Join Forces to Develop Therapeutic Drugs to Target...
CHALFONT ST. GILES, England & OSAKA, Japan GE Healthcare and Takeda Pharmaceutical Company announced that they have entered into an alliance agreement for research and development in the field...
View ArticleClik here to view.
Thomas Casey被任命为Acelity公司执行副总裁兼首席财务官
圣安东尼奥 (美国商业资讯)–Acelity L.P. Inc.今天宣布，任命倍受尊敬的财务领导人Thomas Casey为该公司执行副总裁兼首席财务官。 Tom为Acelity带来30年的财务会计、报表、计划编制和分析领域的经验，包括近二十年的高层领导职位经验。最近，Tom曾担任Clear...
View ArticleClik here to view.
エリテックが大腸菌由来およびエルウィニア菌由来のアスパラギナーゼにアレルギーを持つALL患者でのGRASPA®使用についての良好な初期結果をASHにて発表へ
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（Euronext Paris: FR0011471135 –...
View ArticleClik here to view.
pSivida Reports ILUVIEN® Granted Marketing Authorization in Belgium
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that the Belgian Federal...
View ArticleClik here to view.
Acelityがトーマス・ケーシーを執行副社長兼最高財務責任者に任命
サンアントニオ （ビジネスワイヤ） — Acelityは本日、財務責任者として高い評価を得てきたトーマス・ケーシーを執行副社長兼最高財務責任者（CFO）に任命したと発表しました。...
View ArticleClik here to view.
Expanding Economies in the APAC region will Bolster the Global Medical...
LONDON TechNavio, a tech-focused research firm, has published a new report on the Global Medical Simulation Market, which is expected to post a CAGR of 14.15 percent from 2015-2019. According to the...
View ArticleClik here to view.
X-spine to Exhibit Class-Leading Spinal Devices on Both Sides of the Pacific
MIAMISBURG, Ohio X-spine Systems, Inc., a global medical device manufacturer of class-leading products for spinal surgery, announces that they will be exhibiting their comprehensive portfolio of...
View ArticleClik here to view.
R-Tech Ueno: Lawsuit Claiming Infringement of AMITIZA® Capsules Patents
TOKYO R-Tech Ueno (JASDAQ:4573): Sucampo Pharmaceuticals, Inc. (“Sucampo”) announced that it, together with R-Tech Ueno, Ltd., Sucampo AG, and Takeda Pharmaceutical Company Limited (“Takeda”) and...
View ArticleClik here to view.
Renowned Japanese Scholar Takashi Gojobori Receives Honorary Doctorate from NCKU
TAINAN, Taiwan Dr. Takashi Gojobori, a world-renowned expert on molecular evolution and comparative genomics, received an honorary doctoral degree from National Cheng Kung University (NCKU),...
View ArticleClik here to view.
Phyathai Nawamin International Hospital Thailand Now Offers Shoulder...
BANGKOK Phyathai Nawamin International hospital offers new technology for Shoulder Arthroscopy surgery with tiny camera called “Arthroscope”. The instrument is inserted through a small incision in...
View ArticleClik here to view.
Immune Checkpoint Inhibitors Market to Witness 24.1% Annualised Growth,...
LONDON Roots Analysis has announced the addition of “Immune Checkpoint Inhibitors Market, 2014-2024” report to their offering. The study offers a comprehensive view of the emerging market of CTLA-4,...
View ArticleClik here to view.
Dutch Insurer VGZ Chooses Physitrack as Technology Partner
AMSTERDAM One of the largest health insurers in The Netherlands, VGZ, is partnering with global online rehabilitation platform Physitrack. By cooperating with Physitrack, VGZ offers its contracted...
View ArticleClik here to view.
Clik here to view.
全球调研发现，欧美许多人基本上不了解胰腺癌这一主要的致死性癌症
新泽西州萨米特 (美国商业资讯) –当人们听到“癌症”这个词时，首先想到乳腺癌和肺癌，这可能不足为奇，而近期一项6个国家参与的癌症知晓度调研显示，60%的受访者几乎不知道胰腺癌这一主要的癌症杀手。胰腺癌是美国排行第四的癌症相关死因，预计到2020年，将成为美国第二大癌症死因。在欧美，胰腺癌的5年总生存率不到7%；这项生存率多年来一直很低，在美国和欧洲多数国家常见癌症生存率中位列最低之一。...
View ArticleClik here to view.
BeiGene Completes 450 Million RMB (75 Million USD) Financing
BEIJING BeiGene, LTD., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the successful completion of a financing of over 450 million...
View Article